✦ LIBER ✦

Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol

✍ Scribed by Anatoly B. Smulevich; Sumant Khanna; Mariëlle Eerdekens; Keith Karcher; Michelle Kramer; Fred Grossman

Book ID: 118436596
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 277 KB
Volume: 15
Category: Article
ISSN: 0924-977X
DOI: 10.1016/j.euroneuro.2004.06.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A 12-week, double-blind, placebo-control

A 12-week, double-blind, placebo-controlled trial of donepezil adjunctive treatment to risperidone in chronic and stable schizophrenia

✍ Shahin Akhondzadeh; Maryam Gerami; Maryam Noroozian; Narges Karamghadiri; Aboulf 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 479 KB

A 3-week, randomized, placebo-controlled

A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states

✍ Roger S McIntyre; Miriam Cohen; Jun Zhao; Larry Alphs; Thomas A Macek; John Pana 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 322 KB

Risperidone for the treatment of acute m

Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study

✍ Magali Haas; Melissa P DelBello; Gahan Pandina; Stuart Kushner; Ilse Van Hove; I 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB

SYMPTOMATIC AND FUNCTIONAL RECOVERY INDE

SYMPTOMATIC AND FUNCTIONAL RECOVERY INDEX FOR NEGATIVE SYMPTOMS IN A 40-WEEK RANDOMIZED, DOUBLE-BLIND STUDY OF ZIPRASIDONE VERSUS HALOPERIDOL FOLLOWED BY A 3-YEAR DOUBLE-BLIND EXTENSION TRIAL

✍ Stephen M. Stahl; Ashok Malla; John W. Newcomer; Steven G. Potkin; Peter J. Weid 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Efficacy and Safety of Once Daily Linacl

Efficacy and Safety of Once Daily Linaclotide in Patients With Irritable Bowel Syndrome With Constipation: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial Followed by a 4-Week Randomized Withdrawal Period

✍ Satish Rao; Anthony Lembo; Steven J. Shiff; Kelvin Shi; Jeffrey M. Johnston; Har 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 504 KB

Efficacy of adalimumab in the treatment

Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: Results of a twelve-week randomized, double-blind, placebo-controlled trial followed by an open-label extension up to week fifty-two

✍ Hildrun Haibel; Martin Rudwaleit; Joachim Listing; Frank Heldmann; Robert L. Won 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 3 views